How patients navigate quality-of-life challenges associated with geographic atrophy
Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States
Isarna Therapeutics shares positive results from Phase 2 BETTER trial
ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis
Detecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia
ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions
At the 2025 ARVO annual meeting, Prof Sadun shared an exciting update in our understanding of Leber hereditary optic neuropathy
